Karyopharm Therapeutics
KPTI
KPTI
108 hedge funds and large institutions have $737M invested in Karyopharm Therapeutics in 2018 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 43 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% more call options, than puts
Call options by funds: $616K | Put options by funds: $572K
0.65% more ownership
Funds ownership: 4.15% → 4.8% (+0.65%)
Holders
108
Holding in Top 10
2
Calls
$616K
Puts
$572K
Top Buyers
| 1 | +$81M | |
| 2 | +$24.8M | |
| 3 | +$22.9M | |
| 4 |
BlackRock
New York
|
+$22M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$16.7M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$8.77M | |
| 3 | -$7.52M | |
| 4 |
Millennium Management
New York
|
-$3.96M |
| 5 |
JPMorgan Chase & Co
New York
|
-$2.85M |